Summary
Purpose
This study was undertaken to evaluate the radiographie response to two cycles of chemotherapy prior to irradiation in newly diagnosed children with high-grade astrocytomas.Patients and methods. One hundred and thirty children less than 21 years of age with newly-diagnosed highgrade astrocytoma were treated with the ‘eight-drugs-in-one-day’ chemotherapy regimen as part of a phase III multi-institutional Childrens Cancer Group (CCG) trial. Computerized Tomographic (CT) or Magnetic Resonance Image (MRI) scans, obtained after two cycles of chemotherapy had been administered, were compared with post-operative scans to determine treatment response. Scans were evaluated by institutional radiologists, and were reviewed centrally by a single neuroradiologist.
Results
Of 79 patients with evaluable post-operative residual tumor on CT or MRI scans, 26 (33%) were determined on institutional evaluation to have had an objective response. However, central review of scans documented responses on only 14/79 (18%). A significantly higher response rate on central review was observed for those children 36 months of age or less at study entry than for older children (33% v 11%; p < 0.001). However, a higher disease progression rate was also observed for those children 36 months of age or less than for older children (21% v 2.6%; p < 0.001).
Conclusion
In this study, the largest yet reported in newly-diagnosed children with high-grade astrocytomas, the chemotherapy regimen has activity in younger children. The differences in response rates reported by institutional and central review highlight the difficulties inherent in assessing response to brain tumor therapy. However, the study does demonstrate the consistent ability of radiologists to identify disease progression within the institutional and central reviews.
Similar content being viewed by others
References
Pendergrass TW, Milstein JM, Geyer JR, Mulne AF, Kosnik EJ, Morris JD, Heideman RL, Ruymann FB, Stuntz JT, Bleyer WA: Eight drugs in one day chemotherapy for brain tumors. Experience in 107 children and rationale for pre-radiation chemotherapy. J Clin Oncol 5: 1221–1231, 1987
McNemar Q: Note on the Sampling Error of the Differences between Correlated Proportions or Percentages.Psychometrika 12: 153–157, 1947
Olive D, Philip T, Zucker JM, Benz E, Brunat M, Quintana E: Efficacy of ‘8-drugs-in-1 day’ regimen in the treatment of poor risk childhood brain tumors. Eur Paediatr Hematol Oncol 2: 57–58, 1985
Finlay JL: Chemotherapeutic strategies for high-grade astrocytomas of childhood. In: Packer RJ, Bleyer WA, Pochedly C (eds) Monographs in Clinical Pediatrics: Pediatrie Neuro-Oncology: New Trends in Clinical Research. Volume 3, Harwood Academic Publishers, Chur, Switzerland, 1992, pp 176–206
Khan AB, D'Souza BJ, Wharam MD, Champion LAA, Sinks LF, Woo SY, McCullough DC, Leventhal BG: Cisplatin therapy in recurrent childhood brain tumors. Cancer Treat Rep 66: 2013–2020, 1982
Diez B, Monges J, Sackmann Muriel F: Evaluation of cisplatin in children with recurrent brain tumors. Cancer Treat Rep 69: 911–913, 1985
Sexauer CL, Khan A, Burger PC, Krischer JP, vanEys J, Vats T, Ragab AH: Cisplatin in recurrent brain tumors: a POG phase II study. Cancer 56: 1497–1501, 1985
Walker RW, Allen JC: Cisplatin in the treatment of recurrent childhood primary brain tumors. J Clin Oncol 6: 62–66, 1988
Bertolone SJ, Baum ES, Krivit W, Hammond GD: A phase II study of cisplatin therapy in recurrent childhood brain tumors. A report from the Childrens Cancer Study Group. J Neurooncol 7: 5–11, 1989
Laohaprasit V, Silbergeld DL, Ojemann GA, Estridge JM, Winn HR: Postoperative CT contrast enhancement following lobectomy for epilepsy. J Neurosurg 73: 392–395, 1990
Penn RD, Walser R, Kurtz D, Ackerman L: Tumor volume, luxury perfusion and regional blood volume changes in man visualized by subtraction computerized tomography. J Neurosurg 44: 449–457, 1976
Cairncross JG, Pexman JHW, Rathbone MP, Delmaestro RF: Postoperative contrast enhancement in patients with brain tumor. Ann Neurol 17: 570–572, 1985
Jeffries BF, Kishore PR, Singh KS, Ghatak NR, Krempa J: Contrast enhancement in the postoperative brain. Radiology 139: 409–413, 1981
Enzmann DR, Britt RH, Yeager AS: Experimental brain abscess evolution: computed tomographic and neuropathologic correlation. Radiology 133: 113–122, 1979
Feely MP, Dempsey PJ: Assessment of the postoperative course of excised brain abscess by computerized tomography. Neurosurgery 5: 49–52, 1979
Laster DW, Moody DM, Ball MR: Resolving intracerebral hematoma: alteration of the ‘ring sign’ with steroids. Am J Roentgenol 130: 935–939, 1978
Anderson JR, Cain KC, Gelber RD, Gelman RS: Analysis and interpretation of the comparison of survival by treatment outcome variables in cancer clinical trials. Cancer Treat Rep 69: 1139–1146, 1985
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Finlay, J.L., Geyer, J.R., Turski, P.A. et al. Pre-irradiation chemotherapy in children with high-grade astrocytoma: Tumor response to two cycles of the ‘8-drugs-in-1-day’ regimen. J Neuro-Oncol 21, 255–265 (1994). https://doi.org/10.1007/BF01063775
Issue Date:
DOI: https://doi.org/10.1007/BF01063775